Freudenberg M A, Galanos C
Max-Planck-Institut für Immunbiologie, Freiburg, Federal Republic of Germany.
Int Rev Immunol. 1990;6(4):207-21. doi: 10.3109/08830189009056632.
Endotoxins (lipopolysaccharides, LPS) are biologically active substances present in the outer membrane of gram-negative bacteria. They induce a spectrum of biological effects which may be harmful or beneficiary for the host. Lipid A is the biologically active part of the LPS molecule. This was demonstrated using soluble forms of lipid A and more recently confirmed further by employing synthetic lipid A. LPS administered into experimental animals circulates as LPS/HDL complex and is cleared from the blood mainly into the liver and spleen. In the liver LPS undergoes partial deacylation however without a loss of toxic activity. Its excretion is effected mainly via the bile into the gut. The lethal toxicity and tolerance inducing properties of LPS are mediated by macrophages through tumor necrosis factor alpha (TNF alpha), which is probably the most important endogenous mediator of the lethal effects of LPS. The lethal toxicity of LPS may be completely inhibited by anti-TNF alpha antibodies.
内毒素(脂多糖,LPS)是革兰氏阴性菌外膜中存在的生物活性物质。它们可诱导一系列对宿主可能有害或有益的生物学效应。脂质A是LPS分子的生物活性部分。这一点已通过脂质A的可溶性形式得到证实,最近通过使用合成脂质A进一步得到确认。给实验动物注射的LPS以LPS/HDL复合物的形式循环,并主要从血液中清除到肝脏和脾脏。在肝脏中,LPS发生部分脱酰基作用,但毒性活性并未丧失。其排泄主要通过胆汁进入肠道。LPS的致死毒性和诱导耐受性的特性由巨噬细胞通过肿瘤坏死因子α(TNFα)介导,TNFα可能是LPS致死效应最重要的内源性介质。LPS的致死毒性可被抗TNFα抗体完全抑制。